SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-061379
Filing Date
2023-05-16
Accepted
2023-05-16 16:07:07
Documents
17
Period of Report
2023-05-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315239d6_8k.htm   iXBRL 8-K 25247
2 EXHIBIT 5.1 tm2315239d6_ex5-1.htm EX-5.1 10964
3 EXHIBIT 99.1 tm2315239d6_ex99-1.htm EX-99.1 5995
7 GRAPHIC tm2315239d6_ex5-1img001.jpg GRAPHIC 6256
8 GRAPHIC tm2315239d6_ex5-1img002.jpg GRAPHIC 1008
9 GRAPHIC tm2315239d6_ex5-1img003.jpg GRAPHIC 1025
  Complete submission text file 0001104659-23-061379.txt   233301

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA anip-20230516.xsd EX-101.SCH 3063
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20230516_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20230516_pre.xml EX-101.PRE 22615
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2315239d6_8k_htm.xml XML 3464
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 23927507
SIC: 2834 Pharmaceutical Preparations